BioDtech Signs Worldwide Licensing Agreement For New Technology To Quickly Detect & Remove Bacterial Toxins; Potential Impact On Healthcare, Hygiene, Homeland Security & Bacterial Warfare

NASHVILLE, Tenn.--(BUSINESS WIRE)--Jan. 17, 2005-- BioDtech, Inc. has announced its exclusive worldwide agreement with the National University of Singapore (NUS) for the use and further development of new technology that will quickly detect, neutralize and remove endotoxin. Endotoxin is a potent fever producing compound associated with the physiological symptoms of bacterial infections which cost the healthcare industry over $17 billion annually.